Atara Biotherapeutics Q3 Earnings Preview: EPS Estimate at (0.13) USD
Atara Biotherapeutics is set to report Q3'26 results on October 29. Revenue is estimated at 800.00 thousand USD and EPS at (0.13) USD; the release time is not specified.
ATRA (Atara Biotherapeutics, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 800.00 thousand USD with EPS (earnings per share) anticipated at (0.13) USD. Learn more de…